Control of Peripheral T Cell Survival: A Delicate Division of Labor between Cytokines and Costimulatory Molecules

Human Immunology

Volumn 67, Issue 6, 2006, Pages 469-477

  Keller, Anna M ^a   Borst, Jannie ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; DEATH RECEPTOR;

APOPTOSIS; BLOOD FLOW; CELL DEATH; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; LYMPHOID ORGAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE BLOOD FLOW;

CELL DEATH; CELL SURVIVAL; CYTOKINES; HUMANS; LYMPHOCYTE ACTIVATION; MITOCHONDRIA; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 33646792619     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.03.013     Document Type: Review

References (91)

1. Frauwirth K.A., and Thompson C.B. Regulation of T lymphocyte metabolism. J Immunol 172 (2004) 4661
2. Ahmed R. Tickling memory T cells. Science 272 (1996) 1904
3. Veiga-Fernandes H., Walter U., Bourgeois C., McLean A., and Rocha B. Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nat Immunol 1 (2000) 47
4. Kaech S.M., Hemby S., Kersh E., and Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111 (2002) 837
5. Lanzavecchia A., and Sallusto F. Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol 2 (2002) 982
6. Wherry E.J., Teichgraber V., Becker T.C., Masopust D., Kaech S.M., Antia R., von Andrian U.H., and Ahmed R. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4 (2003) 225
7. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 15 (2001) 2922
8. Vaux D.L., and Silke J. Iaps, Rings and ubiquitylation. Nat Rev Mol Cell Biol 6 (2005) 287
9. Adams J.M., and Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26 (2001) 61
10. Puthalakath H., and Strasser A. Keeping killers on a tight leash. transcriptional and post-translational control of pro-apoptotic activity of BH3-only proteins. Cell Death Diff 9 (2002) 505
11. Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., Olman P.M., Day C.L., Adams J.M., and Huang D.C. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 17 (2005) 393
12. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., and Korsmeyer S.J. Proapoptotic BAX and BAK. a requisite gateway to mitochondrial dysfunction and death. Science 292 (2001) 727
13. Sentman C.L., Shutter J.R., Hockenbery D., Kanagawa O., and Korsmeyer S.J. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67 (1991) 879
14. Ma A., Pena J.C., Chang B., Margosian E., Davidson L., Alt F.W., and Thompson C.B. Bclx regulates the survival of double-positive thymocytes. Proc Natl Acad Sci USA 92 (1995) 4763
15. Veis D.J., Sorenson C.M., Shutter J.R., and Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75 (1993) 229
16. Motoyama N., Wang F., Roth K.A., Sawa H., Nakayama K., Nakayama K., Negishi I., Senju S., Zhang Q., Fujii S., and Loh D.Y. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267 (1995) 1506
17. Nakayama K., Nakayama K., Negishi I., Kuida K., Shinkal Y., Louie M.C., Fields L.E., Lucas P.J., Stewart V., Alt F.W., and Loh D.Y. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261 (1993) 1584
18. Chao D.T., Linette G.P., Boise L.H., White L.S., Thompson C.B., and Korsmeyer S.J. Bcl-XL and Bcl-2 repress a common pathway of cell death. J Exp Med 182 (1995) 821
19. Opferman J.T., Letai A., Beard C., Sorcinelli M.D., Ong C.C., and Korsmeyer S.J. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426 (2003) 671
20. Bouillet P., Metcalf D., Huang D.C., Tarlinton D.M., Kay T.W., Kontgen F., Adams J.M., and Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286 (1999) 1735
21. Villunger A., Michalak E.M., Coultas L., Mullauer F., Bock G., Ausserlechner M.J., Adams J.M., and Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science 302 (2003) 1036
22. Jeffers J.R., Parganas E., Lee Y., Yang C., Wang J., Brenna J., MacLean K.H., Han J., Chittenden T., Ihle J.N., McKinnon P.J., Cleveland J.L., and Zambetti G.P. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4 (2003) 321
23. Ranger A.M., Zha J., Harada H., Datta S.R., Danial N.K., Gilmore A.P., Kutok J.L., Le Beau M.M., Greenberg M.E., and Korsmeyer S.J. Bad-deficient mice develop diffuse large B cell lymphoma. Proc Natl Acad Sci USA 100 (2003) 9324
24. Danial N.N., Gramm C.F., Scorrano L., Zhang C.Y., Krauss S., Ranger A.M., Datta S.R., Greenberg M.E., Licklider L.J., Lowell B.B., Gygi S.P., and Korsmeyer S.J. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 424 (2003) 952
25. Hildeman D.A., Zhu Y., Mitchell T.C., Bouillet P., Strasser A., Kappler J., and Marrack P. Activated T cell death in vivo mediated by proapoptotic Bcl-2 family member Bim. Immunity 16 (2002) 759
26. Pellegrini M., Belz G., Bouillet P., and Strasser A. Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim. Proc Natl Acad Sci USA 100 (2003) 14175
27. Ye Q., Press B., Kissler S., Yang X.F., Lu L., Bassing C.H., Steckman B.P., Jansson M., Panoutsakopoulou V., Trimble L.A., Alt F.W., and Cantor H. T cell costimulation through CD28 depends on induction of the Bcl-xγ isoform. analysis of Bcl-xγ-deficient mice. J Exp Med 196 (2002) 87
28. Gonzalez J., Orlofsky A., and Prystowsky M.B. A1 is a growth-permissive anti-apoptotic factor mediating postactivation survival in T cells. Blood 101 (2003) 2679
29. Petschner F., Zimmermann C., Strasser A., Grillot D., Nunez G., and Pircher H. Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced deletion but does not influence T cell homeostasis after a viral infection. Eur J Immunol 28 (1998) 560
30. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies. integrating mammalain biology. Cell 104 (2001) 487
31. Peter M.E., and Krammer P. The CD95 (APO-1/Fas) DISC and beyond. Cell Death Diff 10 (2003) 26
32. Huang D.C.S., Hahne M., Schroeter M., Frei K., Fontana A., Villunger A., Newton K., Tschopp J., and Strasser A. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL. Proc Natl Acad Sci USA 96 (1999) 14871
33. Zhang N., and He Y.W. An essential role for c-FLIP in the efficient development of mature T lymphocytes. J Exp Med 202 (2005) 395
34. Salmena L., Lemmers B., Hakem A., Matysiak-Zablocki E., Murakami K., Au P.Y.B., Berry D.M., Tamblyn L., Shehabeldin A., Migon E., Wakeham A., Bouchard D., Yeh W.C., McGlade J.C., Ohashi P.S., and Hakem R. Essential role for caspase 8 in T-cell homeostasis and T cell mediated immunity. Genes Dev 17 (2003) 883
35. Dhein J., Walczak H., Baumler C., Debatin K.M., and Krammer P.H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373 (1995) 438
36. Ju S.T., Panka D.J., Cui H., Ettinger R., el Khatib M., Sherr D.H., Stanger B.Z., and Marshak-Rothstein A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373 (1995) 444
37. Lenardo M.J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353 (1991) 858
38. Lohman B.L., Razvi E.S., and Welsh R.M. T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J Virol 70 (1996) 8199
39. Reich A., Korner H., Sedgwick J.D., and Pircher H. Immune down-regulation and peripheral deletion of CD8 T cells does not require TNF receptor-ligand interactions nor CD95 (Fas, APO-1). Eur J Immunol 30 (2000) 678
40. L modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol Cell Biol 22 (2002) 5419
41. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434 (2005) 88
42. Rieux-Laucat F., Le Deist F., Hivroz C., Roberts I.A., Debatin K.M., Fischer A., and de Villartay J.P. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268 (1995) 1347
43. Siegel R.M., Chan F.K., Chun H.J., and Lenardo M.J. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 1 (2000) 469
44. Cohen P.L., and Eisenberg R.A. Lpr and gld. single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9 (1991) 243
45. Fortner K.A., and Budd R.C. The death receptor Fas (CD95/APO-1) mediates the deletion of T lymphocytes undergoing homeostatic proliferation. J Immunol 175 (2005) 4374
46. Arens R., Baars P.A., Jak M., Tesselaar K., van der Valk M., van Oers M.H., and van Lier R.A. Cutting edge. CD95 maintains effector T cell homeostasis in chronic immune activation. J Immunol 174 (2005) 5915
47. Marrack P., and Kappler J. Control of T cell viability. Annu Rev Immunol 22 (2004) 765
48. Amaravadi R., and Thompson C.B. The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 115 (2005) 2618
49. Birkenkamp K.U., and Coffer P.J. FOXO transcription factors as regulators of immune homeostasis. molecules to die for?. J Immunol 171 (2003) 1623
50. Wang C.Y., Guttridge D.C., Mayo M.W., and Baldwin Jr. A.S. NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 19 (1999) 5923
51. Micheau O., Lens S., Gaide O., Alevizopoulos K., and Tschopp J. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 21 (2001) 5299
52. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., and Baldwin Jr. A.S. NF- kappaB antiapoptosis. induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281 (1998) 1680
53. Fox C.J., Hammermann P.S., and Thompson C.B. The Pim kinases control rapamycin-resistant T cell survival and activation. J Exp Med 201 (2005) 259
54. Vivien L., Benoist C., and Mathis D. T lymphocytes need IL-7 but not IL-4 or IL-6 to survive in vivo. Int Immunol 13 (2001) 763
55. Tan J.T., Dudl E., LeRoy E., Murray R., Sprent J., Weinberg K.I., and Surh C.D. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 98 (2001) 8732
56. Akashi K., Kondo M., Freeden-Jeffry U., Murray R., and Weissman I.L. Bcl-2 rescues T lymphopoiesis in Interleukin-7 receptor-deficient mice. Cell 89 (1997) 1033
57. Kim K., Lee C.K., Sayers T.J., Muegge K., and Durum S.K. The trophic action of IL-7 on pro-T cells. inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J Immunol 160 (1998) 5735
58. Rathmell J.C., Farkash E.A., Gao W., and Thompson C.B. IL-7 enhances the survival and maintains the size of naive T cells. J Immunol 167 (2001) 6869
59. Schluns K.S., Kieper W.C., Jameson S.C., and Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 1 (2000) 426
60. Schluns K.S., and Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 3 (2003) 269
61. D'Souza W.N., and Lefrancois L. IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J Immunol 171 (2003) 5727
62. + T cell survival but not for antigen proliferation. Nat Immunol 1 (2000) 54
63. D'Souza W.N., Schluns K.S., Masopust D., and Lefrancois L. Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses. J Immunol 168 (2002) 5566
64. + T cells. J Exp Med 195 (2002) 1515
65. Kennedy M.K., Glaccum M., Brown S.N., Butz E.A., Viney J.L., Embers M., Matsuki N., Charrier K., Sedger L., Willis C.R., Brasel K., Morrissey P.J., Stocking K., Schuh J.C., Joyce S., and Peschon J.J. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191 (2000) 771
66. Schluns K.S., Williams K., Ma A., Zheng X.X., and Lefrancois L. Cutting edge. requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 168 (2002) 4827
67. Becker T.C., Wherry E.J., Boone D., Murali-Krishna K., Antia R., Ma A., and Ahmed R. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 195 (2002) 1541
68. Acuto O., and Michel F. CD28-mediated co-stimulation. a quantitative support for TCR signaling. Nat Rev Immunol 3 (2003) 939
69. Appleman L.J., Berezovskaya A., Grass I., and Boussiotis V.A. CD28 co-stimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J Immunol 164 (2000) 144
70. Okkenhaug K., Wu L., Garza K.M., La Rose J., Khoo W., Odermatt B., Mak T.W., Ohashi P.S., and Rottapel R. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat Immunol 2 (2001) 325
71. Burr J.S., Savage N.D., Messah G.E., Kimzey S.L., Shaw A.S., Arch R.H., and Green J.M. Cutting edge. distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL. J Immunol 166 (2001) 5331
72. Frauwirth K.A., Riley J.L., Harris M.H., Parry R.V., Rathmell J.C., Plas D.R., Elstrom R.L., June C.H., and Thompson C.B. The CD28 signaling pathway regulates glucose metabolism. Immunity 16 (2002) 769
73. Fox C.J., Hammerman P.S., and Thompson C.B. Fuel feeds function. energy metabolism and the T-cell response. Nat Rev Immunol 5 (2005) 844
74. Hendriks J., Xiao Y., and Borst J. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J Exp Med 198 (2003) 1369
75. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23 (2005) 23
76. Croft M. Co-stimulatory members of the TNFR family. keys to effective T-cell immunity?. Nat Rev Immunol 3 (2003) 609
77. Borst J., Hendriks J., and Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol 17 (2005) 275
78. Tesselaar K., Xiao Y., Arens R., van Schijndel G.M., Schuurhuis D.H., Mebius R.E., Borst J., and van Lier R.A. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J Immunol 170 (2003) 33
79. + memory T cells and their capacity for secondary expansion. J Immunol 175 (2005) 1665
80. Maxwell J.R., Weinberg A., Prell R.A., and Vella A.T. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J Immunol 164 (2000) 107
81. Takahashi C., Mittler R.S., and Vella A.T. Cutting edge. 4-1BB is a bona fide CD8 T cell survival signal. J Immunol 162 (1999) 5037
82. Kopf M., Ruedl C., Schmitz N., Gallimore A., Lefrang K., Ecabert B., Odermatt B., and Bachmann M.F. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 11 (1999) 699
83. Kwon B.S., Hurtado J.C., Lee Z.H., Kwack K.B., Seo S.K., Choi B.K., Koller B.H., Wolisi G., Broxmeyer H.E., and Vinay D.S. Immune responses in 4-1BB (CD137)-deficient mice. J Immunol 168 (2002) 5483
84. Murata K., Ishil N., Takano H., Miura S., Ndhlovu L.C., Nose M., Noda T., and Sugamura K. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J Exp Med 191 (2000) 365
85. DeBenedette M.A., Wen T., Bachmann M.F., Ohashi P.S., Barber B.H., Stocking K.L., Peschon J.J., and Watts T.H. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J Immunol 163 (1999) 4833
86. Hendriks J., Gravestein L.A., Tesselaar K., van Lier R.A., Schumacher T.N., and Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol 1 (2000) 433
87. Rogers P.R., Song J., Gramaglia I., Killeen N., and Croft M. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 15 (2001) 445
88. Lee H.W., Nam K.O., Seo S.K., Kim Y.H., Kang H., and Kwon B.S. 4-1BB cross- linking enhances the survival and cell cycle progression of CD4 T lymphocytes. Cell Immunol 223 (2003) 143
89. Bukczynski B., Wen T., and Watts T.H. Costimulation of human CD28- T cells by 4- 1BB ligand. Eur J Immunol 33 (2003) 446
90. Song J., Salek-Ardakani S., Rogers P.R., Cheng M., van Parijs L., and Croft M. The costimutation-regulated duration of PKB activation controls T cell longevity. Nat Immunol 5 (2004) 150
91. Song J., So T., Cheng M., Tang X., and Croft M. Sustained Survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity 22 (2005) 621